Search

everythinglearnresearchcommunity

for

Search:↓

Using anabolic-androgenic steroids can cause skin problems like acne and hair loss in athletes.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Three specific proteins can turn adult skin cells into hair-growing cells, suggesting a new hair loss treatment.

New drugs for heart disease may be developed from molecules secreted by stem cells.

The regenerative solution, tSVF, is a safe and effective treatment for various conditions like aged skin, scars, wounds, and more, but more research is needed to find the best way to use it.

Testosterone therapy aims to treat hormone deficiencies and various conditions safely and effectively, but requires careful patient monitoring due to potential side effects.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

The document concludes that veterinary dermatologists need more experience and a better approach to treating skin diseases in nonhuman primates.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

Aminopterin was somewhat effective in acute lymphoblastic leukemia in children but did not increase survival time.

New physical methods like electrical currents, ultrasound, and microneedles show promise for improving drug delivery through the skin.

Birth control pills help treat skin and hair growth problems linked to high male hormone levels.

Birth control pills can help manage acne, but dermatologists should know their skin-related side effects, especially when prescribing drugs that can harm unborn babies.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The document concludes that there are still unknowns about the effectiveness, risks, and detection of performance-enhancing drugs, and doping remains a challenge.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Pro-IGF-II improves muscle repair in old mice.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Gelatin microspheres with stem cells speed up healing in diabetic wounds.